Statement Of Cash Flows [Abstract]

Carl Zeiss Meditec AG - Filing #6472612

Concept As at
2024-09-30
2023-10-01 to
2024-09-30
As at
2023-09-30
2022-10-01 to
2023-09-30
As at
2022-09-30
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities
12,283 EUR
3,951 EUR
Income taxes paid (refund), classified as operating activities
116,583 EUR
107,106 EUR
Cash flows from (used in) operating activities
247,319 EUR
250,861 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
1.006.279 EUR
10,664 EUR
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
0 EUR
2,423 EUR
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
3,904 EUR
21,594 EUR
Purchase of property, plant and equipment, classified as investing activities
86,814 EUR
65,651 EUR
Purchase of intangible assets, classified as investing activities
65,390 EUR
48,210 EUR
Cash flows from (used in) investing activities
412,305 EUR
110,980 EUR
Cash flows from (used in) financing activities [abstract]
Payments to acquire or redeem entity's shares
150,075 EUR
0 EUR
Proceeds from borrowings, classified as financing activities
400,000 EUR
0 EUR
Payments of lease liabilities, classified as financing activities
23,303 EUR
22,990 EUR
Cash flows from (used in) financing activities
176,249 EUR
135,094 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
1,579 EUR
1,915 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
9,684 EUR
2,872 EUR
Cash and cash equivalents
20,285 EUR
10,601 EUR
7,729 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.